278 related articles for article (PubMed ID: 17388218)
41. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
[TBL] [Abstract][Full Text] [Related]
42. Imiquimod in the treatment of lentigo maligna.
Rajpar SF; Marsden JR
Br J Dermatol; 2006 Oct; 155(4):653-6. PubMed ID: 16965411
[TBL] [Abstract][Full Text] [Related]
43. [How I treat ... lentigo maligna by topical imiquimod].
Bourguignon R; Paquet P; Quatresooz P; Piérard GE
Rev Med Liege; 2005 Sep; 60(9):691-4. PubMed ID: 16265961
[TBL] [Abstract][Full Text] [Related]
44. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases.
de Troya-Martín M; Frieyro-Elicegui M; Fúnez Liébana R; Aguilar Bernier M; Fernández-Canedo NI; Blázquez Sánchez N
Dermatol Surg; 2008 Nov; 34(11):1561-6. PubMed ID: 18798748
[No Abstract] [Full Text] [Related]
45. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
van Meurs T; van Doorn R; Kirtschig G
Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
[No Abstract] [Full Text] [Related]
46. Periocular lentigo maligna treated with imiquimod.
O'Neill J; Ayers D; Kenealy J
J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
[TBL] [Abstract][Full Text] [Related]
47. Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study.
Marsden JR; Fox R; Boota NM; Cook M; Wheatley K; Billingham LJ; Steven NM;
Br J Dermatol; 2017 May; 176(5):1148-1154. PubMed ID: 27714781
[TBL] [Abstract][Full Text] [Related]
48. Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Donigan JM; Hyde MA; Goldgar DE; Hadley ML; Bowling M; Bowen GM
JAMA Dermatol; 2018 Aug; 154(8):885-889. PubMed ID: 29847610
[TBL] [Abstract][Full Text] [Related]
49. Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment.
Kwak R; Joyce C; Werchniak AE; Lin JY; Tsibris HC
J Dermatolog Treat; 2022 Jun; 33(4):1995-1999. PubMed ID: 34315342
[TBL] [Abstract][Full Text] [Related]
50. Treatment of lentigo maligna with topical imiquimod.
Naylor MF; Crowson N; Kuwahara R; Teague K; Garcia C; Mackinnis C; Haque R; Odom C; Jankey C; Cornelison RL
Br J Dermatol; 2003 Nov; 149 Suppl 66():66-70. PubMed ID: 14616356
[TBL] [Abstract][Full Text] [Related]
51. Imiquimod: a novel treatment for lentigo maligna.
Ahmed I; Berth-Jones J
Br J Dermatol; 2000 Oct; 143(4):843-5. PubMed ID: 11069469
[TBL] [Abstract][Full Text] [Related]
52. Imiquimod use in the treatment of lentigo maligna.
Junkins-Hopkins JM
J Am Acad Dermatol; 2009 Nov; 61(5):865-7. PubMed ID: 19836644
[TBL] [Abstract][Full Text] [Related]
53. [Imiquimod in the treatment of lentigo maligna].
Nagore E; Botella-Estrada R
Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
[No Abstract] [Full Text] [Related]
54. Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.
Neumann I; Patalay R; Kaushik M; Timlin H; Daniel C
Eye (Lond); 2023 Feb; 37(3):408-414. PubMed ID: 35835989
[TBL] [Abstract][Full Text] [Related]
55. Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up.
Chambers M; Swetter SM; Baker C; Saunders E; Chapman MS
J Drugs Dermatol; 2021 Mar; 20(3):346-348. PubMed ID: 33683087
[TBL] [Abstract][Full Text] [Related]
56. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
Bartenjev MS; Isaković-Vidović S; Bartenjev I
Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
[TBL] [Abstract][Full Text] [Related]
57. [Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek].
Cheikhrouhou H; Pouaha J; Claeys A; Truchetet F
Ann Dermatol Venereol; 2010 Feb; 137(2):142-4. PubMed ID: 20171439
[No Abstract] [Full Text] [Related]
58. Should topical imiquimod be used for positive margins in lentigo maligna?
Wang TS; Griffiths CC; Roman EM
J Am Acad Dermatol; 2021 Aug; 85(2):521-522. PubMed ID: 32387661
[No Abstract] [Full Text] [Related]
59. Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna.
Micantonio T; Fargnoli MC; Peris K
Arch Dermatol; 2006 Apr; 142(4):530-1. PubMed ID: 16618884
[No Abstract] [Full Text] [Related]
60. Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma.
Matas-Nadal C; Sòria X; García-de-la-Fuente MR; Huerva V; Ortega E; Vilardell F; Gatius S; Casanova JM; Martí RM
J Dermatol; 2018 May; 45(5):564-570. PubMed ID: 29430695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
